Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer
Condition:   Prostate CancerInterventions:   Drug: Apalutamide;   Drug: IHTSponsors:   Robert J Amato;   Janssen Scientific Affairs, LLCNot yet recruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2016 Category: Research Source Type: clinical trials

Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients
Conditions:   Burns;   Growth Hormone Treatment Interventions:   Drug: Somatropin;   Drug: 0.09% Saline Solution Sponsors:   The University of Texas Medical Branch, Galveston;   United States Department of Defense;   Pfizer Recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2016 Category: Research Source Type: clinical trials

Treatment of Canadian Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Condition:   HR+ HER2- Postmenopausal Advanced Breast CancerInterventions:   Drug: Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant;   Drug: Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapySponsor:   Novartis PharmaceuticalsRecruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2016 Category: Research Source Type: clinical trials

ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer.
Condition:   Breast CancerIntervention:   Drug: EribulinSponsor:   Imperial College LondonRecruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2016 Category: Research Source Type: clinical trials